Humoral and cellular immune responses eleven months after the third dose of BNT162b2 an mRNA-based COVID-19 vaccine in people with HIV – a prospective observational cohort studyResearch in context

Summary: Background: We investigated long-term durability of humoral and cellular immune responses to third dose of BNT162b2 in people with HIV (PWH) and controls. Methods: In 378 PWH with undetectable viral replication and 224 matched controls vaccinated with three doses of BNT162b2, we measured I...

Szczegółowa specyfikacja

Opis bibliograficzny

Główni autorzy:	Line Dam Heftdal, Laura Pérez-Alós, Rasmus Bo Hasselbalch, Cecilie Bo Hansen, Sebastian Rask Hamm, Dina Leth Møller, Mia Pries-Heje, Kamille Fogh, Jan Gerstoft, Kirsten Grønbæk, Sisse Rye Ostrowski, Ruth Frikke-Schmidt, Erik Sørensen, Linda Hilsted, Henning Bundgaard, Peter Garred, Kasper Iversen, Caroline Sabin, Susanne Dam Nielsen
Format:	Artigo
Język:	Inglês
Wydane:	Elsevier 2023-07-01
Seria:	EBioMedicine
Hasła przedmiotowe:	BNT162b2 HIV SARS-CoV-2 Immune response Booster dose
Dostęp online:	http://www.sciencedirect.com/science/article/pii/S2352396423002268
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!